SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING
CGPI 0.00010000.0%Jul 21 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (128)12/22/2005 12:35:37 PM
From: Gator II   of 142
 
Too bad there aren't others interested in this company or your message board. We are on a winner. The net profit projections for 2006 don't look so good but I think the company will be back in the black before the end of the year. The key is the new drug hitting the market on schedule. It might come early. Management says everything is ahead of schedule but isn't projecting an early release. The nearly 30 million dollars they just got from the shelf listing plus the cash they had on hand have doubled the book value per share. They can now buy another company without getting permission from the preferred shareholders. They didn't pay much for what they bought and with the licensed products they already have, CGPI should keep the new sales force sharp before the ND is commercialized. Twenty may not be a pipedream before mid-year.
G-2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext